DotLab Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
DotLab General Information
Description
Operator of an AI- and ML-powered women's healthcare platform intended to aid in the early and accurate diagnosis of active endometriosis. The company offers a non-invasive blood test that uses a multi-analyte, algorithmic approach to detect the disease across all stages regardless of hormones, cycle, or symptoms, enabling women and clinicians to achieve faster diagnosis and initiate timely treatment.
Contact Information
Website
www.dotlab.comCorporate Office
- New York, NY
- United States
Corporate Office
- New York, NY
- United States
DotLab Timeline
DotLab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 13-Sep-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 03-Jun-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2019 | $225K | $200K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2016 | $200K | $200K | Completed | Startup |
DotLab Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DotLab Patents
DotLab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4750910-A1 | Artificial intelligence methods and systems for determining endometriosis status | Pending | 24-Jul-2023 | ||
| WO-2025024616-A1 | Artificial intelligence methods and systems for determining endometriosis status | Inactive | 24-Jul-2023 | ||
| EP-4751097-A1 | Methods and compositions for assessing rna levels in biological samples | Pending | 24-Jul-2023 | ||
| WO-2025024591-A1 | Methods and compositions for assessing rna levels in biological samples | Inactive | 24-Jul-2023 | ||
| AU-2020265577-A1 | Classifiers for detection of endometriosis | Inactive | 29-Apr-2019 | C12Q1/6883 |
DotLab Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kapor Capital | Venture Capital | Minority | ||
| Morgan Stanley Inclusive & Sustainable Ventures | Accelerator/Incubator | |||
| CooperSurgical | Corporation | Minority | ||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Government | |||
| Berkeley SkyDeck | Accelerator/Incubator | Minority |
DotLab FAQs
-
When was DotLab founded?
DotLab was founded in 2016.
-
Where is DotLab headquartered?
DotLab is headquartered in New York, NY.
-
What industry is DotLab in?
DotLab’s primary industry is Biotechnology.
-
Is DotLab a private or public company?
DotLab is a Private company.
-
What is DotLab’s current revenue?
The current revenue for DotLab is .
-
How much funding has DotLab raised over time?
DotLab has raised $10.4M.
-
Who are DotLab’s investors?
Kapor Capital, Morgan Stanley Inclusive & Sustainable Ventures, CooperSurgical, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Berkeley SkyDeck have invested in DotLab.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process